N-3 Fatty acids and cardiovascular disease: The story is not over yet

Aging Clinical and Experimental Research

Volumn 25, Issue 4, 2013, Pages 357-363

  Bilato, Claudio ^a  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

Cardiovascular disease; n 3 PUFAs; Observational studies; RCTs

Indexed keywords

ALPHA TOCOPHEROL; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID;

ACUTE HEART INFARCTION; ARTICLE; CARDIOVASCULAR DISEASE; DRUG EFFICACY; HUMAN; ISCHEMIC HEART DISEASE; OBSERVATIONAL STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY;

ANIMALS; CARDIOVASCULAR DISEASES; CLINICAL TRIALS AS TOPIC; FATTY ACIDS, OMEGA-3; HUMANS;

EID: 84886698566     PISSN: 15940667     EISSN: 17208319     Source Type: Journal    
DOI: 10.1007/s40520-013-0077-y     Document Type: Article

References (41)

1. Kromhout D, Yasuda S, Geleijnse JM, Shimokawa H (2012) Fish oil and omega-3 fatty acids in cardiovascular disease: do they really work? Eur Heart J 33:436-443
2. ESC/EAS Guidelines for the Management of Dyslipidemia (2011) Eur Heart J 32:1769-1818
3. European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (2012) Eur Heart J 33:1635-1701
4. Mozaffarian D, Lemaitre RN, King IB, Song X, Huang H, Sacks FM, Rimm EB, Wang M, Siscovick DS (2013) Plasma phospholipid long-chain ω-3 fatty acids and total and cause-specific mortality in older adults: a cohort study. Ann Intern Med 158:515-525
5. Bang HO, Dyeberg J (1973) The composition of food consumed by Greenlandic Eskimos. Acta Med Scand 200:69-73
6. Kroman N, Green A (1980) Epidemiologic studies in the Upernavick District, Greenland: incidence of some chronic disease 1950-1974. Acta Med Scand 208:401-406
7. Daviglus ML, Stamler J, Orencia AJ, Dyer AR, Liu K, Greenland P et al (1997) Fish consumption and the 30-year risk of fatal myocardial infarction. N Engl J Med 336:1046-1053
8. Kromhout D, Bosschieter EB, de Lezenne Coulander C (1985) The inverse relationship between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med 312:1205-1209
9. Rodriguez BL, Sharp DS, Abbott RD, Burchfiel CM, Masaki K, Chyou PH et al (1996) Fish intake may limit the increase in risk of coronary heart disease morbility and mortality among heavy smokers: The Honolulu Heart Programme. Circulation 94:952-956
10. Hu FB, Bronner L, Willett WC, Stampfer MJ, Rexrode KM, Albert CM et al (2002) Fish and omega-3 fatty acids intake and the risk of sudden death in women. JAMA 287:1815-1821
11. Marckmann P, Grønbaek M (1999) Fish consumption and coronary heart disease mortality: a systematic review of prospected cohort studies. Eur J Clin Nutr 53:585-590
12. Siscovick DS, Raghunathan TE, King I, Weinmann S, Wicklund KG, Albright J et al (1995) Dietary intake and cell membrane levels of long-chain omega-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA 274:1363-1367
13. Albert CM, Hennekens CH, O'Donnell CJ, Ajani UA, Carey VJ, Willett WC et al (1998) Fish consumption and risk of sudden cardiac death. JAMA 279:23-28
14. Albert CM, Campos H, Stampfer MJ, Ridker PM, Manson JE, Willett WC et al (2002) Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med 346:1113-1118
15. Tavani A, Pelucchi C, Negri E, Bertuzzi M, La Vecchia C (2001) n-3 polyunsaturated fatty acids, fish, non fatal acute myocardial infarction. Circulation 104:2269-2272
16. Burr ML, Fehily AM, Gilbert JF, Rogers S, Holliday RM, Sweetnam PM et al (1989) Effect of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 30:757-761
17. De Lorgeril M, Renaud S, Mamelle N, Salen P, Martin JL, Monjaud I, Guidollet J, Touboul P, Delaye J (1994) Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet 343:1454-1459
18. GISSI-Prevenzione Investigators (1999) Dietary supplement with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 354:447-455
19. Marchioli R, Barzi F, Bomba E, Chieffo C, Di Gregorio D, Di Mascio R et al (2002) Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppoitaliano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 105:1897-1903
20. Billman GE, Hallaq H, Leaf A (1994) Prevention of ischemia-induced arrhythmias by n-3 fatty acids. Proc Natl Acad Sci USA 91:4427-4430
21. Kang JX, Leaf A (1994) Effects of long-chain polyunsaturated fatty acids on contraction of neonatal rat cardiac myocytes. Proc Natl Acad Sci USA 91:9886-9890
22. Leaf A, Kang JX, Xiao YF, Billman GE (2003) Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils. Circulation 107:2646-2652
23. Christensen JH, Skou HA, Fog L et al (2001) Marine n-3 fatty acids, wine intake, and heart variability in patients referred for coronary angiography. Circulation 103:651-657
24. Investigators GISSI-HF (2008) Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomized, double-blind, placebo-controlled trial. Lancet 372:1223-1230
25. Yokoyama M, Origasa H, Matsuzaki M et al (2007) Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomized open-label, blinded endpoint analysis. Lancet 369:1090-1098
26. Bosch J, Gerstein HC, Dagenais GR, Diaz R et al (2012) n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. N Engl J Med 367:309-318
27. The Risk and Prevention Study Collaborative Group (2013) n-3 fatty acids in patients with multiple cardiovascular risk. New Engl J Med 368:1800-1808
28. Rauch B, Schiele R, Scneider S, OMEGA Study Group et al (2010) OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction. Circulation 122:2152-2159
29. Kromhout D, Giltay EJ, Geleijnse JM (2010) n-3 Fatty acids and cardiovascular events after myocardial infarction. N Engl J Med 363:2015-2026
30. Dhein S, Michaelis B, Mohr FW (2005) Antiarrhythmic and electrophysiological effects of long-chain omega-3 polyunsaturated fatty acids. Naunyn Schmiedebergs Arch Pharmacol 371:202-211
31. Macchia A, Romero M, D'Ettorre A, Tognoni G, Mrini J (2013) Exploratory analysis on the use of statins with or without n-3 PUFA and major events in patients discharged for acute myocardial infarction: an observational retrospectivestudy. PLos One 8:e62772. doi: 10.1371/journal.pone.0062772 Print2013
32. Chen Q, Cheng LQ, Xiao TH et al (2011) Effects of omega-3 fatty acid for sudden cardiac death prevention in patients with cardiovascular disease: a contemporary meta-analysis of randomized, controlled trials. Cardiovasc Drugs Ther 25:259-265
33. Filion KB, El Khoury F, Bielinski M et al (2010) Omega-3 fatty acids in high-risk cardiovascular patients: a meta-analysis of randomized controlled trials. BMC Cardiovasc Disord 10(24):1-11
34. Marik PE, Varon J (2009) Omega-3 dietary supplements and the risk of cardiovascular events: a systematic review. Clin Cardiol 32:365-372
35. Zhao YT, Chen Q, Sun YX et al (2009) Prevention of sudden death with omega-3 fatty acids in patients with coronary heart disease: a meta-analysis of randomized controlled trials. Ann Med 41:301-310
36. Kwak SM, Myung SK, Lee YJ et al (2012) Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease. Arch Intern Med 172:686-694
37. Delgado-Lista J, Perez-Martinez P, Lopez-Miranda J, Perez-Jimenez F (2012) Long chain omega-3 fatty acids and cardiovascular disease: a systematic review. Br J Nutr 107:S201-S213
38. Rizos EC, Ntzani EE, Bika E, Kostapanos MS, Elisaf MS (2012) Association between omega-3 fatty acids supplementation and risk of major cardiovascular disease events. A systematic review and metanalysis. JAMA 308:1024-1033
39. Galli C, Brenna JT (2013) Omega -3 fatty acid supplementation and cardiovascular disease events (letter). JAMA 309:27-29
40. Vlachopoulos C, Richter D, Stefanidis C (2013) Omega-3 fatty acid supplementation and cardiovascular disease events (letter). JAMA 309:27-29
41. Vlachopoulos C, Terentes-Printzios D, Richter D et al (2013) Omega-3 polyunsaturated fatty acid supplements dose and cardiovascular events: a systematic review and meta-analysis. JACC 61:E1421 (abst.)